Lymphoma Rounds: Seattle – POSTPONED
Crowne Plaza Seattle Downtown (click here for directions)
1113 6th Avenue
Seattle, WA 98101
6:00 PM – 8:30 PM
Stephen D. Smith, MD
The University of Washington
Fred Hutchinson Cancer Research Center
This program is free for healthcare professionals; however, pre-registration is required. Food and refreshments will be provided for all registered participants.
Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Sarah Quinlan, firstname.lastname@example.org. Exhibit opportunities are also available, however, space is limited.
Companies that have secured a national exhibit sponsorship for Lymphoma Rounds must still RSVP by emailing Sarah Quinlan (email@example.com) at least one week before the program to confirm their attendance. Otherwise, an exhibit table will not be guaranteed.
ABOUT THE PROGRAM
The Lymphoma Rounds program provides a forum for local practicing physicians from academic and community medical centers to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Physicians network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the local area.
At the conclusion of this educational activity, the participant should be better able to:
- Summarize the latest developments in lymphoma diagnosis, treatment and management.
- Apply best practices for treating lymphoma patients.
- Inform patients about potential clinical trial opportunities.
- Establish a network of health care professionals who work with lymphoma patients.
This program completes the 2019-20 Seattle Rounds series.
Seattle Lymphoma Rounds Steering Committee
Kaiser Permanente Washington
Eric Chen, MD, PhD
Sherry Hu, MD, PhD
Swedish Medical Center
Krish Patel, MD
University of Washington
Paul S. Martin, MD (chair)
University of Washington/Fred Hutchinson Cancer Research Center
Stephen D. Smith, MD
Virginia Mason Medical Center
David Aboulafia, MD
Joint Providership Statement
This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and the Lymphoma Research Foundation.
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Lymphoma Research Foundation and the University of Nebraska Medical Center, Center for Continuing Education
This activity is supported by educational grants from:
AbbVie, Inc., Acrotech Biopharma, LLC, AstraZeneca, BTG International, Inc., Celgene Corporation, Janssen Scientific Affairs, LLC and Pharmacyclics, LLC, an AbbVie Company, Kite Pharma, Inc., Novartis Pharmaceuticals Corporation, Seattle Genetics, Inc., TG Therapeutics, Inc. and Verastem, Inc.